Literature DB >> 9420265

Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.

R Gareus1, A Gigler, A Hemauer, M Leruez-Ville, F Morinet, H Wolf, S Modrow.   

Abstract

Parvovirus B19 infections are associated with diverse clinical manifestations, ranging from no symptoms to severe symptoms. The virus shows an extreme tropism for replication in erythroid progenitor cells, possibly due to the activity of the only functional promoter (p6) of the B19 virus genome in combination with both cell- and cell cycle-specific factors and the trans-activator protein NS1. As presented here, p6 promoter sequences derived from several B19 virus isolates proved to be highly conserved. Furthermore, mutations did not affect any of the potential binding sites for transcription factors. One variation of the base at position 223 was identified only in B19 virus isolates derived from patients with persistent infection or chronic arthritis. To determine promoter activity and to characterize regulatory elements, sequences spanning the total p6 promoter and subfragments of them were introduced into a eukaryotic expression vector upstream of the luciferase gene (from Photinus pyralis). After transfection into HeLa, CEM, BJAB, and K562 cells, the p6 promoter was found to be highly active. When introduced into the erythroid cell line K562, p6-controlled transcription exceeded that of the simian virus 40 promoter-enhancer used as a control by more than 25-fold. Sequence elements relevant for promoter activity mapped to the regions from nucleotides (nt) 100 to 190 and 233 to 298. Also, the segment from nt 343 to 400 downstream of the TATA box was important for transcriptional activity in HeLa and K562 cells. By transfecting the promoter-luciferase constructs into a HeLa cell line stably carrying the viral NS1 gene under the control of an inducible promoter, transcriptional activity mediated by the p6 promoter rose significantly after induction of NS1 expression. The region from nt 100 to 160 proved to be essential for NS1-mediated transcriptional activation. Furthermore, NS1-mediated transactivation was dependent on the presence of two GC-rich elements arranged in tandem upstream of the TATA box. These data indicate that NS1-mediated p6 transactivation is dependent on a multicomponent complex combining NS1 with ATF, NF-kappaB/c-Rel, and GC-box binding cellular factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420265      PMCID: PMC109414     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini.

Authors:  V Deiss; J D Tratschin; M Weitz; G Siegl
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

2.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

3.  Human parvovirus, the cause of erythema infectiosum (fifth disease)?

Authors:  M J Anderson; S E Jones; S P Fisher-Hoch; E Lewis; S M Hall; C L Bartlett; B J Cohen; P P Mortimer; M S Pereira
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

4.  The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.

Authors:  K Ozawa; J Ayub; S Kajigaya; T Shimada; N Young
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells.

Authors:  S Mader; J H White
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

6.  Sequence variability among different parvovirus B19 isolates.

Authors:  A Hemauer; A von Poblotzki; A Gigler; P Cassinotti; G Siegl; H Wolf; S Modrow
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

7.  A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.

Authors:  S Moffatt; N Tanaka; K Tada; M Nose; M Nakamura; O Muraoka; T Hirano; K Sugamura
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Characterization of the trans-activation-responsive element of the parvovirus H-1 P38 promoter.

Authors:  S L Rhode; S M Richard
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

9.  Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.

Authors:  N Sol; F Morinet; M Alizon; U Hazan
Journal:  J Gen Virol       Date:  1993-09       Impact factor: 3.891

10.  Characterization of a virus that causes transient aplastic crisis.

Authors:  N S Young; P P Mortimer; J G Moore; R K Humphries
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more
  25 in total

1.  Genetic diversity within human erythroviruses: identification of three genotypes.

Authors:  Annabelle Servant; Syria Laperche; Francis Lallemand; Valérie Marinho; Guillemette De Saint Maur; Jean François Meritet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

3.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.

Authors:  Masashi Suzuki; Yuko Yoto; Aki Ishikawa; Hiroyuki Tsutsumi
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

5.  Parvovirus B19 integration into human CD36+ erythroid progenitor cells.

Authors:  Tyler Janovitz; Susan Wong; Neal S Young; Thiago Oliveira; Erik Falck-Pedersen
Journal:  Virology       Date:  2017-08-12       Impact factor: 3.616

6.  Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.

Authors:  Johannes Blümel; Anna Maria Eis-Hübinger; Albert Stühler; Claudia Bönsch; Matthias Gessner; Johannes Löwer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA.

Authors:  Sunil Kumar Tewary; Haiyan Zhao; Xuefeng Deng; Jianming Qiu; Liang Tang
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

8.  Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Authors:  Yong Luo; Steve Kleiboeker; Xuefeng Deng; Jianming Qiu
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.

Authors:  Peng Xu; Aaron Yun Chen; Safder S Ganaie; Fang Cheng; Weiran Shen; Xiaomei Wang; Steve Kleiboeker; Yi Li; Jianming Qiu
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

10.  Structure of the NS1 protein N-terminal origin recognition/nickase domain from the emerging human bocavirus.

Authors:  Sunil Kumar Tewary; Haiyan Zhao; Weiran Shen; Jianming Qiu; Liang Tang
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.